These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 21194166)

  • 1. Pulmonary surfactant in respiratory syncytial virus bronchiolitis: the role in pathogenesis and clinical implications.
    Barreira ER; Precioso AR; Bousso A
    Pediatr Pulmonol; 2011 May; 46(5):415-20. PubMed ID: 21194166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Respiratory syncytial virus and pulmonary surfactant.
    Griese M
    Viral Immunol; 2002; 15(2):357-63. PubMed ID: 12081017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma surfactant protein-B is elevated in infants with respiratory syncytial virus-induced bronchiolitis.
    Wang SZ; Doyle IR; Nicholas TE; Forsyth KD
    Pediatr Res; 1999 Dec; 46(6):731-4. PubMed ID: 10590031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel pathways in the pathogenesis of respiratory syncytial virus disease.
    van Schaik SM; Welliver RC; Kimpen JL
    Pediatr Pulmonol; 2000 Aug; 30(2):131-8. PubMed ID: 10922135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exogenous surfactant supplementation in infants with respiratory syncytial virus bronchiolitis.
    Tibby SM; Hatherill M; Wright SM; Wilson P; Postle AD; Murdoch IA
    Am J Respir Crit Care Med; 2000 Oct; 162(4 Pt 1):1251-6. PubMed ID: 11029326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surfactant protein levels in severe respiratory syncytial virus infection.
    Kerr MH; Paton JY
    Am J Respir Crit Care Med; 1999 Apr; 159(4 Pt 1):1115-8. PubMed ID: 10194154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophils in respiratory syncytial virus infection: A target for asthma prevention.
    Geerdink RJ; Pillay J; Meyaard L; Bont L
    J Allergy Clin Immunol; 2015 Oct; 136(4):838-47. PubMed ID: 26277597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Respiratory syncytial virus: the virus, the disease and the immune response.
    Ogra PL
    Paediatr Respir Rev; 2004; 5 Suppl A():S119-26. PubMed ID: 14980256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual proinflammatory and antiviral properties of pulmonary eosinophils in respiratory syncytial virus vaccine-enhanced disease.
    Su YC; Townsend D; Herrero LJ; Zaid A; Rolph MS; Gahan ME; Nelson MA; Rudd PA; Matthaei KI; Foster PS; Dent L; Tripp RA; Lee J; Simson L; Mahalingam S
    J Virol; 2015 Feb; 89(3):1564-78. PubMed ID: 25410867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological mechanisms of severe respiratory syncytial virus bronchiolitis.
    Bont L; Kimpen JL
    Intensive Care Med; 2002 May; 28(5):616-21. PubMed ID: 12029411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin 9 production in the lungs of infants with severe respiratory syncytial virus bronchiolitis.
    McNamara PS; Flanagan BF; Baldwin LM; Newland P; Hart CA; Smyth RL
    Lancet; 2004 Mar; 363(9414):1031-7. PubMed ID: 15051283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of chemokines in the lungs of infants with severe respiratory syncytial virus bronchiolitis.
    McNamara PS; Flanagan BF; Hart CA; Smyth RL
    J Infect Dis; 2005 Apr; 191(8):1225-32. PubMed ID: 15776367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surfactant protein D gene polymorphism associated with severe respiratory syncytial virus infection.
    Lahti M; Lofgren J; Marttila R; Renko M; Klaavuniemi T; Haataja R; Ramet M; Hallman M
    Pediatr Res; 2002 Jun; 51(6):696-9. PubMed ID: 12032263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis of respiratory syncytial virus bronchiolitis-related wheezing.
    Psarras S; Papadopoulos NG; Johnston SL
    Paediatr Respir Rev; 2004; 5 Suppl A():S179-84. PubMed ID: 14980267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel expression of a functional trimeric fragment of human SP-A with efficacy in neutralisation of RSV.
    Watson A; Kronqvist N; Spalluto CM; Griffiths M; Staples KJ; Wilkinson T; Holmskov U; Sorensen GL; Rising A; Johansson J; Madsen J; Clark H
    Immunobiology; 2017 Feb; 222(2):111-118. PubMed ID: 27793398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human respiratory syncytial virus A2 strain replicates and induces innate immune responses by respiratory epithelia of neonatal lambs.
    Olivier A; Gallup J; de Macedo MM; Varga SM; Ackermann M
    Int J Exp Pathol; 2009 Aug; 90(4):431-8. PubMed ID: 19659901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surfactant protein-A enhances uptake of respiratory syncytial virus by monocytes and U937 macrophages.
    Barr FE; Pedigo H; Johnson TR; Shepherd VL
    Am J Respir Cell Mol Biol; 2000 Nov; 23(5):586-92. PubMed ID: 11062136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Respiratory Syncytial Virus: Role of Innate Immunity in Clearance and Disease Progression.
    Farrag MA; Almajhdi FN
    Viral Immunol; 2016; 29(1):11-26. PubMed ID: 26679242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between surfactant protein A gene locus and severe respiratory syncytial virus infection in infants.
    Löfgren J; Rämet M; Renko M; Marttila R; Hallman M
    J Infect Dis; 2002 Feb; 185(3):283-9. PubMed ID: 11807709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective control of vitamin D receptor-mediated epithelial STAT1 signalling predisposes to severe respiratory syncytial virus bronchiolitis.
    Stoppelenburg AJ; von Hegedus JH; Huis in't Veld R; Bont L; Boes M
    J Pathol; 2014 Jan; 232(1):57-64. PubMed ID: 24105653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.